{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:06:25Z","timestamp":1779426385238,"version":"3.53.1"},"reference-count":64,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Aspirin, initially recognized for its anti-inflammatory, antipyretic and analgesic properties, holds a prominent role in the treatment of cardiovascular disease. The utility of aspirin in cancer therapeutics has been explored and stratified into COX-dependent and -independent mechanisms. COX2 gene expression has been demonstrated to be significantly upregulated in colorectal cancer and various other gastrointestinal malignancies including pancreatic, esophageal, and gastric cancer. This study investigates the relationship of aspirin use and outcomes in patients with colorectal cancer. Methods: The Nationwide Inpatient Sample (NIS) database from 2017 to 2022 was analyzed for patients age &gt; 18 who were hospitalized for colorectal cancer and its decompensations using ICD-10 diagnostic codes. These patients were further stratified based on the long-term use of aspirin. The principal outcome of this investigation are the odds of in-hospital mortality, with secondary outcomes including odds of pulmonary embolism, portal vein thrombosis, acute kidney injury, septic shock, requiring an ICU level of care and odds of hepatic, pulmonary, gastrointestinal and peritoneal or retroperitoneal metastatic disease. Multivariate logistic regression accounting for hospital and patient characteristics was implemented for analysis, with the Charlson Comorbidity Index used to adjust for coexisting comorbidity burden; a p-value (p) of &lt;0.05 was considered statistically significant. Results: In our analysis of the NIS, 596,160 patients were identified with colorectal cancer and 11.7% (69,750) of this population were identified with long-term use of aspirin. Aspirin use was identified to have a significantly reduced odds of in-patient mortality (adjusted odds ratio) [aOR] 0.530, p value &lt; 0.001 95% CI (confidence interval): 0.460\u20130.617. Patients with aspirin use also demonstrated significantly reduced odds of adverse outcomes and gastrointestinal, hepatic, pulmonary and retroperitoneal\/peritoneal metastasis; (aOR 0.606, 95% CI: 0.564\u20130.653, p &lt; 0.001), (aOR 0.628, 95% CI: 0.582\u20130.678, p &lt; 0.001), (aOR 0.676, 95% CI: 0.605\u20130.755, p &lt; 0.001) and (aOR 0.751, 95% CI: 0.685\u20130.825, p &lt; 0.001) respectively. Conclusions: In recent years, there has been an alarming increase in incidence of colorectal cancer, particularly amongst younger individuals with increased associated mortality. This mortality increase, albeit alarming, is a driving force for treatment innovation with continual examination of our repertoire of medications for possible repurposed applications. COX2-mediated signaling serves as a key promotor of tumorigenic molecular signaling that directly contributes to tumor cell proliferation, angiogenesis and metastasis in colorectal cancer. Aspirin use and its inhibitory action on COX2 demonstrated a significantly reduced odds of in-hospital mortality. Aspirin use is also associated with significantly reduced odds of developing metastatic disease to the liver, gastrointestinal system, lungs and peritoneum in patients with colorectal cancer. These findings convey that aspirin use reduces the likelihood of in-hospital mortality, major comorbid conditions and of developing metastatic disease as compared to those who do not use aspirin.<\/jats:p>","DOI":"10.3390\/jcm15103894","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:35:43Z","timestamp":1779176143000},"page":"3894","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Aspirin Use on In-Hospital Outcomes and Metastatic Disease in Colorectal Cancer: An Evaluation of the National Inpatient Sample"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5465-9609","authenticated-orcid":false,"given":"Omar A.","family":"Oudit","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Brookdale University Hospital Medical Center, Brooklyn, NY 11212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temitayo","family":"Adebowale","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, Columbia Irving Medical Center, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Atasi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Brookdale University Hospital Medical Center, Brooklyn, NY 11212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kibwey","family":"Peterkin","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Yale University, New Haven, CT 06511, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Perry","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Cincinnati, Cincinnati, OH 45219, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidiebele E.","family":"Omaliko","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Brookdale University Hospital Medical Center, Brooklyn, NY 11212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Brooklyn Hospital Center, Brooklyn, NY 11201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"ref_1","first-page":"e70005","article-title":"Exploring Aspirin\u2019s Potential in Cancer Prevention: A Comprehensive Review of the Current Evidence","volume":"16","author":"Rawat","year":"2024","journal-title":"Cureus"},{"key":"ref_2","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","unstructured":"National Cancer Institute (2018). Surveillance, epidemiology, and end results (SEER) program. Cancer Statistics, SEER Data & Software, Registry Operations, National Cancer Institute."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Gurpinar, E., Grizzle, W.E., and Piazza, G.A. (2013). COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs. Front. Oncol., 3.","DOI":"10.3389\/fonc.2013.00181"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3349\/ymj.2007.48.3.495","article-title":"Expression of Cyclooxygenase-2 and its Relationship to p53 Accumulation in Colorectal Cancers","volume":"48","author":"Lim","year":"2007","journal-title":"Yonsei Med. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2048731","DOI":"10.1155\/2016\/2048731","article-title":"Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy","volume":"2016","author":"Pang","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2009.1112","article-title":"Aspirin Use and Survival After Diagnosis of Colorectal Cancer","volume":"302","author":"Chan","year":"2009","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3332\/ecancer.2021.1258","article-title":"Aspirin and cancer survival: A systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers","volume":"15","author":"Elwood","year":"2021","journal-title":"Ecancermedicalscience"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/gutjnl-2014-308260","article-title":"Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: A meta-analysis","volume":"64","author":"Li","year":"2015","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.294.8.914","article-title":"Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in Men and Women","volume":"294","author":"Chan","year":"2005","journal-title":"JAMA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.21037\/jgo.2018.08.13","article-title":"The relationship between aspirin use and mortality in colorectal cancer","volume":"9","author":"Albandar","year":"2018","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.31557\/APJCP.2019.20.6.1675","article-title":"Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients","volume":"20","author":"Negi","year":"2019","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.3748\/wjg.v21.i20.6206","article-title":"Expression of COX-2 and HER-2 in colorectal cancer and their correlation","volume":"21","author":"Wu","year":"2015","journal-title":"World J. Gastroenterol. WJG"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Roelofs, H.M., Nagengast, F.M., and Peters, W.H. (2014). Over-expression of COX-2 mRNA in colorectal cancer. BMC Gastroenterol., 14.","DOI":"10.1186\/1471-230X-14-1"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/15384047.2017.1294292","article-title":"Chronic inflammation confers to the metabolic reprogramming associated with tumorigenesis of colorectal cancer","volume":"18","author":"Qu","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"G59","DOI":"10.1152\/ajpgi.00101.2014","article-title":"Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention","volume":"309","author":"Fajardo","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.56782\/pps.229","article-title":"Review of the effects of sodium butyrate on obesity, inflammatory bowel disease, pregnancy and colorectal cancer","volume":"22","author":"Flegiel","year":"2024","journal-title":"Prospect. Pharm. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Liebl, M.C., and Hofmann, T.G. (2021). The Role of p53 Signaling in Colorectal Cancer. Cancers, 13.","DOI":"10.3390\/cancers13092125"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1007\/s13277-015-4438-3","article-title":"Aspirin acetylates wild type and mutant p53 in colon cancer cells: Identification of aspirin acetylated sites on recombinant p53","volume":"37","author":"Ai","year":"2016","journal-title":"Tumour. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wang, Q., Shen, X., Chen, G., and Du, J. (2022). Drug Resistance in Colorectal Cancer: From Mechanism to Clinic. Cancers, 14.","DOI":"10.3390\/cancers14122928"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100114","DOI":"10.1016\/j.adcanc.2024.100114","article-title":"Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success","volume":"10","author":"Ashique","year":"2024","journal-title":"Adv. Cancer Biol.-Metastasis"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Chen, L., Yang, F., Chen, S., and Tai, J. (2022). Mechanisms on chemotherapy resistance of colorectal cancer stem cells and research progress of reverse transformation: A mini-review. Front. Med., 9.","DOI":"10.3389\/fmed.2022.995882"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/cam4.4581","article-title":"Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER-Medicare analysis","volume":"11","author":"Ades","year":"2022","journal-title":"Cancer Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e028563","DOI":"10.1136\/bmjopen-2018-028563","article-title":"Incidence of cancer-associated thromboembolism in Japanese gastric and colorectal cancer patients receiving chemotherapy: A single-institutional retrospective cohort analysis (Sapporo CAT study)","volume":"9","author":"Aonuma","year":"2019","journal-title":"BMJ Open"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00384-017-2909-2","article-title":"Colorectal cancer and thrombosis","volume":"33","author":"Rees","year":"2018","journal-title":"Int. J. Color. Dis."},{"key":"ref_27","unstructured":"Rucker, D., and Dhamoon, A.S. (2022, September 12). Physiology, Thromboxane A2. [Updated 12 September 2022], StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539817\/."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Patrono, C., and Rocca, B. (2019). Measurement of Thromboxane Biosynthesis in Health and Disease. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.01244"},{"key":"ref_29","first-page":"231","article-title":"A low dose of aspirin (75 mg\/day) lowers thrombin generation to a similar extent as a high dose of aspirin (300 mg\/day)","volume":"11","author":"Undas","year":"2000","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.asjsur.2016.07.013","article-title":"Colorectal cancer with venous tumor thrombosis","volume":"41","author":"Otani","year":"2018","journal-title":"Asian J. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4103\/wjnm.WJNM_84_19","article-title":"Diagnosis of portal vein tumor thrombosis in colorectal carcinoma in fluorodeoxyglucose positron emission tomography\u2013computed tomography scan and its clinical implication","volume":"19","author":"Shah","year":"2020","journal-title":"World J. Nucl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e16382","DOI":"10.1200\/JCO.2024.42.16_suppl.e16382","article-title":"Portal vein thrombosis in gastrointestinal cancers: Insights into prevalence and prognosis\u2014A nationwide inpatient analysis 2018\u20132020","volume":"42","author":"Ginjupalli","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00280-016-2996-8","article-title":"Celecoxib induces apoptosis but up-regulates VEGF via endoplasmic reticulum stress in human colorectal cancer in vitro and in vivo","volume":"77","author":"Xu","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3892\/ol.2012.936","article-title":"Antitumor effect of the selective COX-2 inhibitor celecoxib on endometrial adenocarcinoma in vitro and in vivo","volume":"4","author":"Xiao","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_36","first-page":"6277","article-title":"Current concepts in colorectal cancer prevention with cyclooxygenase inhibitors","volume":"34","author":"Ranger","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/onc.2009.421","article-title":"The Role of COX-2 in Intestinal Inflammation and Colorectal Cancer","volume":"29","author":"Wang","year":"2009","journal-title":"Oncogene"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.7150\/ijms.44439","article-title":"The Role of Cyclooxygenase-2 in Colorectal cancer","volume":"17","author":"Sheng","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3748\/wjg.v29.i9.1395","article-title":"Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond","volume":"29","author":"Doughan","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Oh, J.M., Kim, S., Tsung, C., Kent, E., Jain, A., Ruff, S.M., and Zhang, H. (2025). Comprehensive review of the resistance mechanisms of colorectal cancer classified by therapy type. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1571731"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"20816","DOI":"10.1002\/jcp.28687","article-title":"Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p\/Oct4 axis","volume":"234","author":"Tang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41586-025-08626-7","article-title":"Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity","volume":"640","author":"Yang","year":"2025","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MCG.0000000000002045","article-title":"Exploring the Protective Role of Aspirin Use in Mitigating Colorectal Cancer (CRC) Metastasis: A Nationwide Analysis (2016 to 2020)","volume":"59","author":"Paladiya","year":"2025","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2504650","article-title":"ALASCCA Study Group. Low-dose aspirin for PI3K-altered localized colorectal cancer","volume":"393","author":"Martling","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S2468-1253(24)00393-5","article-title":"Adjuvant aspirin therapy and colorectal cancer survival","volume":"10","author":"Lee","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"106857","DOI":"10.1016\/j.jff.2025.106857","article-title":"The role of inflammation in colorectal Cancer and the preventive potential of natural compounds","volume":"129","author":"Aboulaghras","year":"2025","journal-title":"J. Funct. Foods"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: Pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.7150\/ijbs.46651","article-title":"The Role of Interleukins in Colorectal Cancer","volume":"16","author":"Li","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12964-020-00557-2","article-title":"Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression","volume":"18","author":"Liu","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/15384047.2017.1360453","article-title":"Metastatic colon adenocarcinoma has a significantly elevated expression of IL-10 compared with primary colon adenocarcinoma tumors","volume":"19","author":"Townsend","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Waldner, M.J., and Neurath, M.F. (2023). TGF\u03b2 and the Tumor Microenvironment in Colorectal Cancer. Cells, 12.","DOI":"10.3390\/cells12081139"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e137112","DOI":"10.1172\/jci.insight.137112","article-title":"MUC1-C drives stemness in progression of colitis to colorectal cancer","volume":"5","author":"Li","year":"2020","journal-title":"JCI Insight"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-020-01156-y","article-title":"Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance","volume":"19","author":"Pothuraju","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00428-016-1970-5","article-title":"MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: Expression profiles and clinical significance","volume":"469","author":"Betge","year":"2016","journal-title":"Virchows Arch."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s40121-021-00433-7","article-title":"Fatal Infections Among Cancer Patients: A Population-Based Study in the United States","volume":"10","author":"Zheng","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"ref_57","first-page":"487","article-title":"Infectious complications of advanced cancer","volume":"8","author":"Homsi","year":"2000","journal-title":"Support Care Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Andresen, K., Carreira, H., Strongman, H., McDonald, H.I., Benitez-Majano, S., Mansfield, K.E., Nitsch, D., Tomlinson, L.A., and Bhaskaran, K. (2023). The risk of acute kidney injury in colorectal cancer survivors: An english population-based matched cohort study. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-11329-9"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ckj\/sfaa127","article-title":"Preventive strategies for acute kidney injury in cancer patients","volume":"14","author":"Cosmai","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"295","DOI":"10.23876\/j.krcp.19.042","article-title":"Acute kidney injury in the patient with cancer","volume":"38","author":"Rosner","year":"2019","journal-title":"Kidney Res. Clin. Pract."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13613-024-01335-w","article-title":"Long term cognitive dysfunction among critical care survivors: Associated factors and quality of life\u2014A multicenter cohort study","volume":"14","author":"Santos","year":"2024","journal-title":"Ann. Intensive Care"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"103106","DOI":"10.1016\/j.iccn.2021.103106","article-title":"Incidence and influencing factors of post-intensive care cognitive impairment","volume":"67","author":"Yao","year":"2021","journal-title":"Intensive Crit. Care Nurs."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1056\/NEJMoa1301372","article-title":"Long-term cognitive impairment after critical illness","volume":"369","author":"Pandharipande","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e929","DOI":"10.1002\/ams2.929","article-title":"Post-intensive care syndrome: Recent advances and future directions","volume":"11","author":"Inoue","year":"2024","journal-title":"Acute Med. Surg."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/10\/3894\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:17:52Z","timestamp":1779423472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/10\/3894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":64,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["jcm15103894"],"URL":"https:\/\/doi.org\/10.3390\/jcm15103894","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]}}}